Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

35.63 -0.52 (-1.44%)
Streaming Delayed Price Updated: 2:37 PM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,102,644
Open 35.85
Bid (Size) 35.61 (500)
Ask (Size) 35.65 (300)
Prev. Close 36.15
Today's Range 35.00 - 36.15
52wk Range 18.92 - 48.55
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
1 Bold Prediction for Viking Therapeutics in 2026 ↗
Viking's pipeline may release its value next year, and larger companies are likely to consider acquiring it. 
Via The Motley Fool
News headline image
2 Monster Stocks in the Making to Buy and Hold ↗
The next 12 months will tell us more about their prospects. 
Via The Motley Fool

Performance

YTD
-13.4%
-13.4%
1 Month
-6.8%
-6.8%
3 Month
+47.9%
+47.9%
6 Month
+32.2%
+32.2%
1 Year
-24.6%
-24.6%

More News

Read More
News headline image
My Top 10 Stocks to Buy for 2026 ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
3 Underrated Growth Stocks That Look Like Great Buys Heading Into 2026 ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs
Eli Lilly, Novo Nordisk Or A Dark Horse: Which Obesity-Drug Stock Are Retail Traders Most Bullish On Over Next 5 Years? ↗
Via Stocktwits
News headline image
What's Up With The Jump In Viking Therapeutics Stock? ↗
Via Benzinga
News headline image
Prediction: This Undervalued Stock Could Compete With Novo Nordisk by 2029 ↗
Via The Motley Fool
News headline image
Retail Traders Crown Novo Nordisk As Long-Term Weight Loss King — Even As Eli Lilly Hits $1T And Viking Fans Tout ‘M&A Prize’ ↗
Via Stocktwits
News headline image
2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Mid-Cap Growth Stocks That Have Mammoth Long-Term Potential ↗
Via The Motley Fool
News headline image
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗
Via The Motley Fool
News headline image
5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
2 No-Brainer Healthcare Stocks to Buy Now ↗
Via The Motley Fool
News headline image
Druckenmiller Opens Position In Amazon, Closes Microsoft — Here's More Of Duquesne's Biggest Q3 Moves ↗
Via Benzinga
News headline image
Viking Therapeutics Stock Soars To 10-Month High After Canaccord Boost – Retail Traders See It As Next Big Obesity Play ↗
Via Stocktwits
‘Somebody Knows Something:’ Viking Therapeutics Stock Pops To Nearly 3-Month High As Retail Traders Intensely Speculate On M&A Scenarios ↗
Via Stocktwits
News headline image
AMD, Oklo, AppLovin Corp, Viking Therapeutics And Novo Nordisk: Why These 5 Stocks Are On Investors' Radars Today ↗
Via Benzinga
Topics Stocks
News headline image
2 Monster Stocks in the Making ↗
Via The Motley Fool
News headline image
Novo Nordisk Loses Metsera Bidding War To Pfizer — But Retail Traders Aren’t Losing Faith ↗
Via Stocktwits
News headline image
Is There a Future for Viking Therapeutics? ↗
Via The Motley Fool
News headline image
The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things. ↗
Via Investor's Business Daily
Topics Government
News headline image
Druckenmiller's Viking Trade Just Hit A Golden Cross — And A Sweet 36% Gain ↗
Via Benzinga
News headline image
Jim Cramer Says 'Take A Pass' On This Tech Stock, Won't Go Near Oils ↗
Via Benzinga
News headline image
Here's Why Shares in Viking Therapeutics Shot Higher in October ↗
Via The Motley Fool
News headline image
Billionaire Stanley Druckenmiller Dropped Nvidia and Palantir Stock and Is Piling into 2 Stocks Set to Win in One of the Decade's Hottest Growth Markets. ↗
Via The Motley Fool
Topics Artificial Intelligence

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 35.63
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 12/16/25 02:37 PM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 3.55B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.